Goveia MG - Search Results

1

Projecting the effectiveness of RotaTeq® against rotavirus-related hospitalisations in Brazil.

El Khoury AC, Mast TC, Ciarlet M, Markson L, Goveia MG, Munford V, Rácz ML. El Khoury AC, et al. Among authors: goveia mg. Mem Inst Oswaldo Cruz. 2011 Aug;106(5):541-5. doi: 10.1590/s0074-02762011000500004. Mem Inst Oswaldo Cruz. 2011. PMID: 21894373 Free article.

2

RotaTeq: Progress toward developing world access.

Goveia MG, Nelson CB, Ciarlet M. Goveia MG, et al. J Infect Dis. 2010 Sep 1;202 Suppl:S87-92. doi: 10.1086/653546. J Infect Dis. 2010. PMID: 20684723

3

Projecting the effectiveness of RotaTeq® against rotavirus-related hospitalizations and deaths in six Asian countries.

El Khoury AC, Mast TC, Ciarlet M, Markson LE, Goveia MG. El Khoury AC, et al. Among authors: goveia mg. Hum Vaccin. 2011 May;7(5):506-10. doi: 10.4161/hv.7.5.14620. Epub 2011 May 1. Hum Vaccin. 2011. PMID: 21422820 Free PMC article.

4

Development, clinical evaluation, and post-licensure impact of RotaTeq, a pentavalent rotavirus vaccine.

Goveia MG, Ciarlet M, Owen KE, Ranucci CS. Goveia MG, et al. Ann N Y Acad Sci. 2011 Mar;1222:14-8. doi: 10.1111/j.1749-6632.2011.05970.x. Ann N Y Acad Sci. 2011. PMID: 21434938 Review.

5

Burden of rotavirus gastroenteritis and distribution of rotavirus strains in Asia: a systematic review.

Kawai K, O'Brien MA, Goveia MG, Mast TC, El Khoury AC. Kawai K, et al. Among authors: goveia mg. Vaccine. 2012 Feb 8;30(7):1244-54. doi: 10.1016/j.vaccine.2011.12.092. Epub 2011 Dec 31. Vaccine. 2012. PMID: 22212128 Review.

6

Heterogeneity of Rotavirus Vaccine Efficacy Among Infants in Developing Countries.

Gruber JF, Hille DA, Liu GF, Kaplan SS, Nelson M, Goveia MG, Mast TC. Gruber JF, et al. Among authors: goveia mg. Pediatr Infect Dis J. 2017 Jan;36(1):72-78. doi: 10.1097/INF.0000000000001362. Pediatr Infect Dis J. 2017. PMID: 27755463

7

Efficacy of the pentavalent rotavirus vaccine, RotaTeq® (RV5), between doses of a 3-dose series and with less than 3 doses (incomplete regimen).

Dennehy PH, Vesikari T, Matson DO, Itzler RF, Dallas MJ, Goveia MG, DiNubile MJ, Heaton PM, Ciarlet M. Dennehy PH, et al. Among authors: goveia mg. Hum Vaccin. 2011 May;7(5):563-8. doi: 10.4161/hv.7.5.15406. Epub 2011 May 1. Hum Vaccin. 2011. PMID: 21441783 Clinical Trial.

8

Analysis by rotavirus gene 6 reverse transcriptase-polymerase chain reaction assay of rotavirus-positive gastroenteritis cases observed during the vaccination phase of the Rotavirus Efficacy and Safety Trial (REST).

Matson DO, Vesikari T, Dennehy P, Dallas MD, Goveia MG, Itzler RF, Ciarlet M. Matson DO, et al. Among authors: goveia mg. Hum Vaccin Immunother. 2014;10(8):2267-75. doi: 10.4161/hv.29176. Hum Vaccin Immunother. 2014. PMID: 25424931 Free PMC article. Clinical Trial.

9

Planning for monitoring the introduction and effectiveness of new vaccines using real-word data and geospatial visualization: An example using rotavirus vaccines with potential application to SARS-CoV-2.

Mast TC, Heyman D, Dasbach E, Roberts C, Goveia MG, Finelli L. Mast TC, et al. Among authors: goveia mg. Vaccine X. 2021 Apr;7:100084. doi: 10.1016/j.jvacx.2021.100084. Epub 2021 Jan 9. Vaccine X. 2021. PMID: 33521625 Free PMC article.

10

Efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequency.

Goveia MG, DiNubile MJ, Dallas MJ, Heaton PM, Kuter BJ; REST Study Team. Goveia MG, et al. Pediatr Infect Dis J. 2008 Jul;27(7):656-8. doi: 10.1097/INF.0b013e318168d29e. Pediatr Infect Dis J. 2008. PMID: 18520448 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters